Neuroone Medical Technologies is trading 6.4% up at $1.66 after announcing ISO 13485-2016 certification on August 11, 2026.

  • The milestone supports international marketing opportunities for its Evo cortical and sEEG electrodes and OneRF Brain Ablation System.
  • It could create nearer-term revenue growth through Zimmer Biomet and distributor partnerships.
  • The certification is a clear company-specific catalyst, although the announcement does not cite trading activity or directly attribute the price move.